The DNTTIP1 Knockout A-549 Polyclonal Cells product is a CRISPR/Cas9-edited polyclonal knockout population derived from the human A-549 lung carcinoma cell line. This heterogeneous cell pool carries target-gene disruptions in DNTTIP1, providing a loss-of-function model to investigate DNTTIP1-dependent transcriptional regulation and chromatin remodeling without the need for clonal isolation.
The A-549 cell line, derived from the lung tissue of a 58-year-old Caucasian male with lung adenocarcinoma, is a well-established adherent epithelial model. Widely utilized in cancer biology, drug metabolism, and respiratory infection research, A-549 cells offer robust growth and well-characterized signaling pathways, making them an ideal chassis for gene knockout studies aimed at dissecting molecular mechanisms of non-small cell lung cancer.
DNTTIP1 functions as a transcriptional repressor by recruiting histone deacetylases (HDAC1/HDAC2) and the INO80 chromatin remodeling complex to target gene promoters. Through direct interaction with the INO80 core subunits (INO80, RUVBL1, RUVBL2) and the NuRD complex component MTA2, DNTTIP1 facilitates histone H3/H4 deacetylation and chromatin compaction, thereby silencing genes involved in cell cycle progression and proliferation. DNTTIP1 is also implicated in the DNA damage response, where it may be regulated by upstream ATM/ATR kinases and interact with terminal deoxynucleotidyltransferase (TdT), linking chromatin state to DNA repair fidelity.
Within the A-549 lung adenocarcinoma model, knockout of DNTTIP1 is anticipated to derepress genes governing cell cycle progression and apoptosis, thereby altering proliferation rates, genomic stability, and responses to HDAC inhibitors. Since A-549 cells carry activating mutations in KRAS and STK11 (LKB1), loss of DNTTIP1-mediated repression may synergize with these oncogenic drivers, revealing vulnerabilities specific to chromatin-dysregulated tumors. This model also provides a relevant context for studying how DNTTIP1-dependent chromatin changes affect DNA damage repair and sensitivity to genotoxic agents.
Researchers can deploy this polyclonal knockout population in a suite of functional genomics experiments: RNA-seq identifies global transcriptional alterations; ChIP-qPCR detects shifts in histone acetylation at specific promoters; Western blotting quantifies bulk acetyl-histone levels; and cell-based assays gauge proliferation, apoptosis, and HDAC inhibitor sensitivity. Additionally, DNA damage signaling can be probed via ATM/ATR pathway activation and ??H2AX foci formation measured by immunofluorescence. For specialized applications or additional information, please contact Ascent Research.
